Pyruvate dehydrogenase kinase inhibitor dichloroacetate augments autophagy mediated constraining the replication of Mycobacteroides massiliense in macrophages

Microbes Infect. 2023 Sep-Oct;25(7):105139. doi: 10.1016/j.micinf.2023.105139. Epub 2023 Apr 19.

Abstract

Increasing evidence indicates a strong interaction between cellular metabolism and innate macrophage immunity. Here, we show that the intracellular replication of Mycobacteroides massiliense in macrophages depends on host pyruvate dehydrogenase kinase (PDK) activity. Infection with M. massiliense induced a metabolic switch in macrophages by increasing glycolysis and decreasing oxidative phosphorylation. Treatment with dichloroacetate (DCA), a PDK inhibitor, converts this switch in M. massiliense-infected macrophages and restricts intracellular bacterial replication. Mechanistically, DCA resulted in AMPKα1 activation via increased AMP/ATP ratio, consequently inducing autophagy to constrain bacterial proliferation in the phagolysosome. This study suggests that the pharmacological inhibition of PDK could be a strategy for host-directed therapy to control virulent M. massiliense infections.

Keywords: Antimicrobial activity; Autophagy; Dichloroacetate; Host immune defense; Mycobacteroides massiliense.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy
  • Glycolysis*
  • Macrophages / metabolism
  • Protein Serine-Threonine Kinases* / metabolism
  • Pyruvate Dehydrogenase Acetyl-Transferring Kinase / metabolism

Substances

  • Pyruvate Dehydrogenase Acetyl-Transferring Kinase
  • Protein Serine-Threonine Kinases